1. Circulating tumor cells in the clinical cancer diagnosis

   • P. Zhang
   • H. Zhou
   • T. Feng

   Review Article 28 May 2019 Pages: 279 - 282

2. Altered expression and functional role of ion channels in leukemia: bench to bedside

   • H. Rafieemehr
   • A. Samimi
   • S. Shahrabi

   Review Article 06 July 2019 Pages: 283 - 293

   

3. Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

   • E. Gobbini
   • R. Chiari
   • S. Novello

   Research Article 19 October 2019 Pages: 294 - 301

   

4. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway

   • Q. Y. Li
   • K. Yang
   • X. S. Liu

   Research Article Open access 17 October 2019 Pages: 302 - 310

   

5. Influence of the technique and comorbidities in hypofractionated radiotherapy for prostate cancer

   • R. Correa
   • I. Navarro
   • J. Gómez-Millán

   Research Article 12 November 2019 Pages: 311 - 318

   

6. The tumor diameter cut-off for predicting microscopic intrahepatic metastasis of hepatocellular carcinoma patients without treatment history differs from that of hepatocellular carcinoma patients with a treatment history

   • Y. Okamura
   • T. Sugiura
   • K. Uesaka

   Research Article 30 April 2019 Pages: 319 - 329

   

7. Coping strategies and depressive symptoms in cancer patients

   • I. Ghanem
   • B. Castelo
   • C. Calderon

   Research Article 10 May 2019 Pages: 330 - 336

8. Cost-effectiveness of trifluridine/tipiracil (TAS102) for heavily pretreated metastatic gastric cancer

   • K. Zhou
   • J. Zhou
   • Q. Li

   Research Article 30 April 2019 Pages: 337 - 343

   

9. Differences of the immune cell landscape between normal and tumor tissue in human prostate

   • E. Zhang
   • F. Dai
   • Y. Qiao

   Research Article 10 May 2019 Pages: 344 - 350

   

10. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

    • A. Fernandez Montes
    • F. Vazquez Rivera
    • J. García Gómez

    Research Article 09 May 2019 Pages: 351 - 359

11. Predictive factors for persistent and late radiation complications in breast cancer survivors

    • F. Fekrmandi
    • T. Panzarella
    • W. Levin

    Research Article 23 May 2019 Pages: 360 - 369

    

12. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy

    • Z.-X. Lin
    • D.-Y. Ruan
    • X.-Y. Wu

    Research Article 14 June 2019 Pages: 370 - 380

    

13. Clinical significance of epithelial–mesenchymal transition-related markers expression in the micrometastatic sentinel lymph node of NSCLC

    • A. Lafuente-Sanchis
    • A. Olmo
    • J. M. Galbis-Caravajal

    Research Article 28 May 2019 Pages: 381 - 391

    

14. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21

    • Jun Chen
    • Zequn Li
    • Shusen Zheng

    Research Article 01 July 2019 Pages: 392 - 400

    

15. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma

    • Shan-Shan Wu
    • Quan-Yuan Shan
    • Wei Wang

    Research Article 06 June 2019 Pages: 401 - 410

    

16. Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab

    • C. Panciroli
    • G. Lucente
    • C. B. Quintero

    Research Article 29 May 2019 Pages: 411 - 419

    

17. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    • J. Gavilá
    • J. De La Haba
    • A. Llombart-Cussac

    Research Article 15 June 2019 Pages: 420 - 428

    

18. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis

    • R. Zhou
    • J. Zhu
    • T. Zhang

    Research Article 04 June 2019 Pages: 429 - 439

    

19. A new and simple scoring system to predict overall survival after irradiation for metastatic spinal cord compression

    • P. Nenclares
    • S. Guardado
    • J. F. Pérez-Regadera

    Brief Research Article 05 June 2019 Pages: 440 - 444

    

20. De-escalation treatment of axilla in breast cancer

    • G. Corso
    • V. Galimberti
    • P. Veronesi

    Correspondence 09 May 2019 Pages: 445 - 446